SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 44 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $458,921 | -29.8% | 573,651 | 0.0% | 0.00% | – |
| Q2 2023 | $653,962 | -24.0% | 573,651 | 0.0% | 0.00% | – |
| Q1 2023 | $860,476 | +0.7% | 573,651 | 0.0% | 0.00% | – |
| Q4 2022 | $854,740 | -3.9% | 573,651 | +0.0% | 0.00% | – |
| Q3 2022 | $889,000 | -41.5% | 573,456 | -14.4% | 0.00% | – |
| Q2 2022 | $1,520,000 | -12.9% | 669,572 | -11.4% | 0.00% | – |
| Q1 2022 | $1,746,000 | -60.1% | 755,950 | +0.3% | 0.00% | – |
| Q4 2021 | $4,371,000 | -44.4% | 753,695 | +0.9% | 0.00% | – |
| Q3 2021 | $7,856,000 | +107.6% | 746,759 | +92.6% | 0.00% | – |
| Q2 2021 | $3,784,000 | -19.8% | 387,753 | +19.4% | 0.00% | – |
| Q1 2021 | $4,718,000 | – | 324,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 415,000 | $942,000 | 0.18% |
| RA Capital Management | 723,549 | $1,642,000 | 0.04% |
| Duquesne Family Office | 100,000 | $227,000 | 0.02% |
| LEO BROKERAGE, LLC | 14,845 | $34,000 | 0.01% |
| Ergoteles LLC | 93,598 | $212,000 | 0.01% |
| Virtu Financial LLC | 11,223 | $25,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 37,900 | $86,000 | 0.00% |
| Renaissance Technologies | 247,000 | $561,000 | 0.00% |
| UBS Group AG | 13,463 | $31,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 38,776 | $88,000 | 0.00% |